Results
1 -
10 of
62Cincinelli Raffaella, Musso Loana, Merlini Lucio, Giannini Giuseppe, Vesci Loredana, Milazzo Ferdinando M., Carenini Nives, Perego Paola, Penco Sergio, Artali Roberto, Zunino Franco, Pisano Claudio, Dallavalle Sabrina.
7-Azaindole-1-carboxamides as a new class of PARP-1 inhibitors, Bioorganic & Medicinal Chemistry, 2014 Overview of PARP Inhibitor Design and Optimization, PARP Inhibitors for Cancer Therapy PARP Inhibitors, Current Breast Cancer Reports Preclinical Chemosensitization by PARP Inhibitors, PARP Inhibitors for Cancer Therapy Classification of PARP Inhibitors Based on PARP Trapping and Catalytic Inhibition, and Rationale for Combinations with Topoisomerase I Inhibitors and Alkylating Agents, PARP Inhibitors for Cancer Therapy Introduction to PARPi Clinical Trials and Future Directions, PARP Inhibitors for Cancer Therapy Incorporation of Biomarker Assessment in Novel Clinical Trial Designs: Personalizing Brain Tumor Treatments, Current Oncology Reports Advances in Ovarian Cancer and Ongoing Clinical Trials, Gynecological Cancers Clinical Trials Investigating PARP Inhibitors as Single Agents, PARP Inhibitors for Cancer Therapy High-Grade Carcinomas, BRCA Mutations and the Role of PARP Inhibitors, Ovarian Cancers